PRLD

Prelude Therapeutics (PRLD)

About Prelude Therapeutics (PRLD)

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Details

Daily high

$2.06

Daily low

$1.79

Price at open

52 Week High

$4.22

52 Week Low

$0.61

Market cap

150.7M

Dividend yield

0.00%

Volume

440

Avg. volume

435,846

P/E ratio

-1.23

Prelude Therapeutics News